MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yano, H.
Right arrow Articles by Takeda, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yano, H.
Right arrow Articles by Takeda, J.

Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA

H Yano, LH Philipson, JL Kugler, Y Tokuyama, EM Davis, MM Le Beau, DJ Nelson, GI Bell and J Takeda

Howard Hughes Medical Institute, University of Chicago, Illinois 60637.

Recent studies have identified a new family of inwardly rectifying K+ channels, members of which are known by the acronyms ROMK1, IRK1, and GIRK1. We have isolated cDNAs encoding the human homologue of ROMK1 from an adult kidney cDNA library. The sequences of the human kidney ROMK1 cDNA clones indicated that they were derived from at least two types of mRNAs, human ROMK1A and human ROMK1B, differing in sequence at their 5' ends. The isolation of the human ROMK1 gene, localized to chromosome band 11q24 by fluorescence in situ hybridization, indicated that the different ROMK1 transcripts were generated by alternative splicing. Human ROMK1A mRNA was predicted to encode a protein of 389 amino acids, having 93% identity with the 391-residue rat ROMK1 protein, and expression studies in Xenopus oocytes indicated that it encoded a Ba(2+)-sensitive inwardly rectifying K+ channel with properties similar to those reported for cloned rat ROMK1. Human ROMK1B mRNA was predicted to encode a protein of 372 amino acids whose sequence was truncated at the amino terminus but otherwise identical to that of the human ROMK1A protein. Translation of human ROMK1B mRNA was predicted to initiate at a codon corresponding to Met-18 of human ROMK1A mRNA. Reverse transcriptase-polymerase chain reaction amplification of human kidney mRNA revealed human ROMK1A and -B transcripts as well as a third type of transcript, human ROMK1C mRNA, which was predicted to encode a protein identical to human ROMK1B. Human ROMK1A, -B, and -C transcripts were identified in kidney, whereas only human ROMK1A mRNA could be detected in pancreatic islets and other tissues in which human ROMK1 was expressed at low levels. Thus, tissue- specific alternative splicing of human ROMK1 mRNA may result in the expression of a family of ROMK1 proteins.

Volume 45, Issue 5, pp. 854-860, 05/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Physiol.Home page
S. Bendahhou, E. Fournier, D. Sternberg, G. Bassez, A. Furby, C. Sereni, M. R Donaldson, M.-M. Larroque, B. Fontaine, and J. Barhanin
In vivo and in vitro functional characterization of Andersen's syndrome mutations
J. Physiol., June 15, 2005; 565(3): 731 - 741.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. C. Hebert, G. Desir, G. Giebisch, and W. Wang
Molecular Diversity and Regulation of Renal Potassium Channels
Physiol Rev, January 1, 2005; 85(1): 319 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bendahhou, M. R. Donaldson, N. M. Plaster, M. Tristani-Firouzi, Y.-H. Fu, and L. J. Ptacek
Defective Potassium Channel Kir2.1 Trafficking Underlies Andersen-Tawil Syndrome
J. Biol. Chem., December 19, 2003; 278(51): 51779 - 51785.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Pharmacol. Rev., December 1, 2000; 52(4): 557 - 594.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. Lehmann-Horn and K. Jurkat-Rott
Voltage-Gated Ion Channels and Hereditary Disease
Physiol Rev, October 1, 1999; 79(4): 1317 - 1372.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. Yamada, A. Inanobe, and Y. Kurachi
G Protein Regulation of Potassium Ion Channels
Pharmacol. Rev., December 1, 1998; 50(4): 723 - 757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. M. Macica, Y. Yang, K. Lerea, S. C. Hebert, and W. Wang
Role of the NH2 terminus of the cloned renal K+ channel, ROMK1, in arachidonic acid-mediated inhibition
Am J Physiol Renal Physiol, January 1, 1998; 274(1): F175 - F181.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Kubo, T. Miyashita, and K. Kubokawa
A Weakly Inward Rectifying Potassium Channel of the Salmon Brain. GLUTAMATE 179IN THE SECOND TRANSMEMBRANE DOMAIN IS INSUFFICIENT FOR STRONG RECTIFICATION
J. Biol. Chem., June 28, 1996; 271(26): 15729 - 15735.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Karschin, E. Dissmann, W. Stuhmer, and A. Karschin
IRK(1-3) and GIRK(1-4) Inwardly Rectifying K+ Channel mRNAs Are Differentially Expressed in the Adult Rat Brain
J. Neurosci., June 1, 1996; 16(11): 3559 - 3570.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Ferrer, C. G. Nichols, E. N. Makhina, L. Salkoff, J. Bernstein, D. Gerhard, J. Wasson, S. Ramanadham, and A. Permutt
Pancreatic Islet Cells Express a Family of Inwardly Rectifying K[IMAGE] Channel Subunits Which Interact to Form G-protein-activated Channels
J. Biol. Chem., November 3, 1995; 270(44): 26086 - 26091.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics